Abbreviations
- aRTx:
-
Adjuvante Radiotherapie
- HR:
-
Hazard Ratio
- KI:
-
Konfidenzintervall
- PSA:
-
Prostataspezifisches Antigen
- RP:
-
Radikale Prostatektomie
- sRTx:
-
(Early‑)Salvage-Radiotherapie
Literatur
Parker CC, Clarke NW, Cook AD et al (2020) Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet 396(10260):1413–1421. https://doi.org/10.1016/S0140-6736(20)31553-1
Sargos P, Chabaud S, Latorzeff I et al (2020) Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol 21(10):1341–1352
Vale CL, Fisher D, Kneebone A et al (2020) Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Lancet 396(10260):1422–1431
Tilki D, D’Amico AV (2020) Timing of radiotherapy after radical prostatectomy. Lancet 396(10260):1374–1375
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Würnschimmel und D. Tilki geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Würnschimmel, C., Tilki, D. Update zur adjuvanten vs. Early-Salvage-Radiotherapie nach radikaler Prostatektomie. Urologe 60, 790–791 (2021). https://doi.org/10.1007/s00120-021-01501-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-021-01501-z